CBD and older people: precautions, framework and a wellness approach

With age, several factors converge: more structured wellness routines, closer attention to the quality of rest, but also frequent polypharmacy, liver and kidney function that is sometimes less efficient, and heightened sensitivity to adverse effects. The HAS has been publishing recommendations on medication-induced harm in older patients for several years; those principles apply by analogy to the introduction of a product such as CBD.

Wellness CBD is not a medicine: it has no indication validated by the ANSM or by the HAS. It does not treat osteoarthritis, insomnia, anxiety or neuropathic pain; any statement of that kind exposes the seller to penalties, according to the MILDECA. It does not replace medical treatment, in particular treatments prescribed for the chronic conditions common among older people (hypertension, diabetes, chronic pain, cardiac disorders).

This is the most important point for older people. CBD is metabolised by the liver cytochromes CYP3A4 and CYP2C19, which are shared with many prescribed medicines: oral anticoagulants, antiepileptics, statins, certain antihypertensives, antidepressants and anxiolytics, immunosuppressants, and certain painkillers (tramadol, codeine). Any use of CBD must be discussed beforehand with the treating doctor or the pharmacist, particularly in cases of polypharmacy.

Start low. No official dose has been validated. The EFSA proposes a provisional safe daily level of 0.0275 mg/kg/day (≈ 2 mg/day for 70 kg), an order of magnitude that calls for caution. A practical benchmark: start with 5 mg per dose, observe for around ten days, adjust slowly. Our CBD dosage benchmark sets out this progression.

Choose a suitable route. Topical cosmetics (balm, massage oil) offer local action without notable systemic absorption, and are often preferred by older people for muscle comfort. Sublingual oil allows drop-by-drop dose adjustment. Vaporisation is less suitable where there is respiratory fragility.

Favour traceable products. A certificate of analysis (CoA) from an independent laboratory, verified CBD content, THC below 0.30%, and the absence of prohibited cannabinoids, pesticides and heavy metals. Our guide to buying CBD in France sets out these criteria.

Several effects are reported, generally at high doses: drowsiness or unusual tiredness (a fall risk in older people), dry mouth, mild digestive upset, and a drop in blood pressure calling for vigilance with antihypertensives. The ANSES further advises against CBD for pregnant and breastfeeding women and for minors. For older people, add caution in cases of liver disease or kidney failure, specialist advice for progressive neurological conditions, and systematically informing the anaesthetist before surgery.

Medical cannabis, now being rolled out in France following the 2021-2024 trial, is prescribed by a hospital doctor for five specific indications: neuropathic pain, drug-resistant epilepsies, spasticity in multiple sclerosis, oncology and palliative care. Wellness CBD does not fall within that framework. An older person suffering from a serious condition should turn to their doctor, not to a high-street product.

My parents take several medicines, can they try CBD?

Not without medical advice. Interactions via CYP3A4/CYP2C19 involve many molecules. A discussion with the treating doctor or the pharmacist is essential beforehand.

Is CBD reimbursed for older people?

No. Wellness CBD is not a medicine and is not reimbursed by the French health insurance system. Only Epidyolex®, a pharmaceutical CBD for rare epilepsies, holds a hospital marketing authorisation.

Which form is preferable for an older person?

Often topical cosmetics for muscle and joint comfort, and sublingual oils at moderate doses for an evening routine, once a doctor has agreed.

Does a CBD balm relieve osteoarthritis?

No cosmetic may legally claim so. CBD balms belong to a massage and muscle-comfort routine; osteoarthritis calls for medical care.